Suppr超能文献

选择性合成 1-取代-4-氯吡唑并[3,4-d]嘧啶。

Selective synthesis of 1-substituted 4-chloropyrazolo[3,4-d]pyrimidines.

机构信息

PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, New Jersey 07080, United States.

出版信息

Org Lett. 2013 Apr 19;15(8):1882-5. doi: 10.1021/ol4005382. Epub 2013 Apr 10.

Abstract

Strategies for carrying out the reaction of 4,6-dichloropyrimidine-5-carboxaldehyde with various hydrazines to generate 1-substituted 4-chloropyrazolo[3,4-d]pyrimidines in a selective and high-yielding manner are presented. For aromatic hydrazines, the reaction is performed in the absence of an external base, which promotes exclusive hydrazone formation. The hydrazones subsequently cyclize at an elevated temperature to form the desired pyrazolo[3,4-d]pyrimidine products. For aliphatic hydrazines, the reaction sequence proceeds as a single step in the presence of an external base.

摘要

介绍了以选择性和高产率的方式进行 4,6-二氯嘧啶-5-甲醛与各种肼的反应,生成 1-取代的 4-氯吡唑并[3,4-d]嘧啶的策略。对于芳族肼,反应在没有外部碱的情况下进行,这促进了肼的形成。随后,腙在高温下环化形成所需的吡唑并[3,4-d]嘧啶产物。对于脂肪族肼,反应序列在外源碱的存在下以单步进行。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验